London, 01 October 2014: TechNavio, the independent tech-focused global research firm, has published a report on the Global Intracranial Stents Market 2014-2018, which is expected to post a CAGR of 18.75 percent during the period 2013-2018.
Intracranial stents are stainless steel mesh-like tubes with anatomic features to achieve a perfect combination of radial strength and flexibility. They are used in the treatment of cerebral aneurysms, intracranial aneurysms, and intracranial atherosclerosis that cause about 8 percent of all ischemic strokes. Intracranial stents help in strengthening the weakened artery, allowing blood to flow through smoothly.
“The introduction of new intracranial devices with flow-diverters is feasible and effective with high complete occlusion rates, and intraoperative neurophysiological monitoring systems help as a tool for continuous functional monitoring of patients undergoing large-caliber vessel EC-IC bypass surgery,” says Faisal Ghaus, Vice President of TechNavio.
Key Market Drivers
- Increased Incidence of Cerebral Disorders
- Demand for Minimally Invasive Endovascular Surgeries
- Increase in Incidence of Diseases among Aging Population
- Advances in Technology
Key Market Trends
- Rise in Demand for Intracranial Stenting Procedures
- Rise in Recognition and Awareness
Key Market Vendors
- Covidien plc
- DePuy Synthes Inc.
- Medtronic Inc.
- MicroPort Scientific Corp.
- OBEX Medical
- Stryker Corp.
To define the market circumstances in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
